Head-to-head · WeighScore
FuturHealth vs Woodwork
The verdict
Woodwork takes it — 73.2/100 to 65.6/100.
Woodwork grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Woodwork is a men's health telehealth platform built by Grindr that offers compounded GLP-1 weight-loss medications alongside ED care, with a focus on serving gay and queer men.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | FuturHealth | Woodwork |
|---|---|---|
| WeighScore | 65.6/100 | 73.2/100 |
| Grade | C | C |
| Scorecard rank | #215 | #72 |
| Semaglutide | $199/mo (compounded) | $127/mo (starting dose, compounded) |
| Tirzepatide | Not disclosed | $199/mo (starting dose, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Yes |
Graded #215 · C
Strengths
- LegitScript Certified and HITRUST Certified
- Brand-name and oral GLP-1s on one platform: Wegovy injection and pill, Zepbound, Mounjaro, Ozempic, and Foundayo
- Early direct-to-consumer access to Foundayo (orforglipron), the new oral non-peptide GLP-1
- Bundled registered-dietitian nutrition guidance — uncommon among pure-Rx telehealths
Where it loses points
- Active lawsuit (Wilson v. FuturHealth) alleging unauthorized access to G-Plans subscriber data
- BBB complaints describe recurring charges without medication received — confirm cancellation flow first
- Pharmacy partners described only as 'licensed, U.S.-based' with no specific 503A/503B names
- Pricing not shown until after the qualification questionnaire or portal login
- Front-end brand built on SteadyMD and OpenLoop infrastructure, not a first-party prescriber
Graded #72 · C
Strengths
- Low transparent pricing: compounded semaglutide from $127/month, tirzepatide from $199/month, microdose $134/month
- Compounded semaglutide offered as injection or oral tablet
- No separate consult or membership fees
- Free shipping, included lab work, and 1-on-1 care coaching
- HSA and FSA eligible; bundles a free Grindr Unlimited subscription
Where it loses points
- Compounded GLP-1s are not FDA-approved finished products
- Cash-pay only — no insurance billing
- States served are not listed publicly
- No compounding pharmacy partner named and no LegitScript badge shown
- Weight loss is secondary to the platform's men's-health/ED focus
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.